Clinical Trial Update: Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the combination of cetuximab, cisplatin, and radiation therapy for advanced stage III/IV head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• Platinol (cisplatin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED